ATF2 predicts poor prognosis and promotes malignant phenotypes in renal cell carcinoma

BACKGROUND: Activating transcription factor 2 (ATF2) is a basic helix-loop-helix transcription factor, which has been shown to participate in the pathobiology of numerous cancers. However, the role of ATF2 in renal cell carcinoma (RCC) remains unclear. METHODS: ATF2 knockdown and overexpression stud...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Wu, Deng-shuang, Chen, Cheng, Wu, Zhen-jie, Liu, Bing, Gao, Li, Yang, Qing, Chen, Wei, Chen, Jun-ming, Bao, Yi, Qu, Le, Wang, Lin-hui
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4932740/
https://ncbi.nlm.nih.gov/pubmed/27377902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-016-0383-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados